CVRS News and Press, Corindus Vascular Robotics Inc. (DE) From 09/03/19

Renowned medical journal publishes the successful clinical results of remote PCI procedures using CorPath ® GRX Robotic System technology Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of p...

Siemens Healthineers On An Interesting Path Siemens Healthineers AG ( SMMNY ), a subsidiary of Germany’s Siemens AG ([[SIEGY]]) and publicly traded following a 2018 IPO, is focused on healthcare niches that we believe have strong growth prospects. For instance, the digital and robotic...

Merger activity increased last week with seven new deals announced and four pending deals closing. In the context of the merger of Sprint (S) with T-Mobile (TMUS), it was interesting to see a large insider purchase by the Chairman of DISH Network (DISH). Deal Statistics: New Deals: ...

NEW YORK , Aug. 9, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating: Genomic Health, Inc. ( GHDX ) ("Genomic"...

Addus HomeCare (NASDAQ: ADUS ) initiated with Outperform rating at William Blair. More news on: Addus HomeCare Corporation, Denali Therapeutics Inc., Cronos Group Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Corindus Vascular Robotics, Inc. (CVRS) Q2 2019 Earnings Conference Call August 8, 2019 8:30 AM ET Company Participants Judy DiClemente – Investor Relations Mark Toland – Chief Executive Officer David Long – Chief Financial Officer Conference Call Particip...

Gainers : Corindus Vascular Robotics (NYSEMKT: CVRS ) +76% . Vitamin Shoppe (NYSE: VSI ) +41% . Avedro (NASDAQ: AVDR ) +36% . G1 Therapeutics (NASDAQ: GTHX ) +27% . Alpha and Omega Semiconductor (NASDAQ: AOSL ) +22% . Carvana (NYSE: CVNA ) +21% . Roku (NASDAQ: ROKU ) +20% ...

NEW YORK, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Corindus Vascular Robotics, Inc. (NYSE AMERICAN: CVRS) to Siemens Healthineers AG for $4.28 per share is fair to Corindus shareholders. On behalf of Corindus...

Corindus Vascular Robotics (NYSEMKT: CVRS ) +76%  on Q2 results and being acquired by Seimens. More news on: Corindus Vascular Robotics, Inc., Vitamin Shoppe, Inc., Stamps.com Inc., Stocks on the move, Read more ...

Corindus Vascular Robotics (NYSEMKT: CVRS ): Q2 GAAP EPS of -$0.06 misses by $0.02 . More news on: Corindus Vascular Robotics, Inc., Earnings news and commentary, Consumer stocks news, Read more ...